• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过核磁共振对鲎素I和一种新型抗HIV合成肽T22([酪氨酸5,12,赖氨酸7] - 海胆精蛋白II)的溶液结构进行的比较研究。

A comparative study of the solution structures of tachyplesin I and a novel anti-HIV synthetic peptide, T22 ([Tyr5,12, Lys7]-polyphemusin II), determined by nuclear magnetic resonance.

作者信息

Tamamura H, Kuroda M, Masuda M, Otaka A, Funakoshi S, Nakashima H, Yamamoto N, Waki M, Matsumoto A, Lancelin J M

机构信息

Faculty of Pharmaceutical Sciences, Kyoto University, Japan.

出版信息

Biochim Biophys Acta. 1993 May 13;1163(2):209-16. doi: 10.1016/0167-4838(93)90183-r.

DOI:10.1016/0167-4838(93)90183-r
PMID:8490053
Abstract

The solution structure of tachyplesin I, which was isolated from membrane acid extracts of the hemocytes from the Japanese horseshoe crab (Tachypleus tridentatus), was determined by nuclear magnetic resonance (NMR) and distance geometry calculation. Tachyplesin I takes an antiparallel beta-sheet structure with a type-II beta-turn. Recently, among more than 20 synthetic peptides associated with tachyplesin and its isopeptide (polyphemusin), we found that a novel compound, which we designated as T22 ([Tyr5,12, Lys7]-polyphemusin II), strongly inhibited the human immunodeficiency virus (HIV)-1-induced cytopathic effect and viral antigen expression. The solution structure of T22 was investigated using NMR, and its secondary structure was confirmed to be similar to that of tachyplesin I. The anti-parallel beta-sheet structure and the several amino-acid side chains on the plane of the beta-sheet of T22 are thought to be associated with the expression of anti-HIV activity.

摘要

从日本鲎(三刺鲎)血细胞的膜酸提取物中分离得到的鲎素I的溶液结构,通过核磁共振(NMR)和距离几何计算得以确定。鲎素I呈具有II型β-转角的反平行β-折叠结构。最近,在20多种与鲎素及其异肽(鲎抗菌肽)相关的合成肽中,我们发现了一种新型化合物,我们将其命名为T22([酪氨酸⁵,¹², 赖氨酸⁷]-鲎抗菌肽II),它能强烈抑制人类免疫缺陷病毒(HIV)-1诱导的细胞病变效应和病毒抗原表达。利用核磁共振对T22的溶液结构进行了研究,其二级结构被证实与鲎素I相似。T22的反平行β-折叠结构以及β-折叠平面上的几个氨基酸侧链被认为与抗HIV活性的表达有关。

相似文献

1
A comparative study of the solution structures of tachyplesin I and a novel anti-HIV synthetic peptide, T22 ([Tyr5,12, Lys7]-polyphemusin II), determined by nuclear magnetic resonance.通过核磁共振对鲎素I和一种新型抗HIV合成肽T22([酪氨酸5,12,赖氨酸7] - 海胆精蛋白II)的溶液结构进行的比较研究。
Biochim Biophys Acta. 1993 May 13;1163(2):209-16. doi: 10.1016/0167-4838(93)90183-r.
2
A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II).一种新型抗HIV合成肽,T-22([酪氨酸5,12,赖氨酸7] - 多聚半胱氨酸II)
Biochem Biophys Res Commun. 1992 Dec 15;189(2):845-50. doi: 10.1016/0006-291x(92)92280-b.
3
Downsizing of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II), with the maintenance of anti-HIV activity and solution structure.一种HIV细胞融合抑制剂T22([酪氨酸5,12,赖氨酸7] - 海胆精蛋白II)的缩微化,同时保持抗HIV活性和溶液结构。
Bioorg Med Chem. 1998 Apr;6(4):473-9. doi: 10.1016/s0968-0896(97)10055-4.
4
Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion.新型合成肽T22([酪氨酸-5,12,赖氨酸-7]海胆精蛋白II)的抗人免疫缺陷病毒活性:一种可能的病毒-细胞融合抑制剂。
Antimicrob Agents Chemother. 1992 Jun;36(6):1249-55. doi: 10.1128/AAC.36.6.1249.
5
Effective lowly cytotoxic analogs of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II).一种HIV细胞融合抑制剂T22([酪氨酸5,12,赖氨酸7] - 海螯虾抗菌肽II)的高效低细胞毒性类似物
Bioorg Med Chem. 1998 Feb;6(2):231-8. doi: 10.1016/s0968-0896(97)10037-2.
6
Antimicrobial peptide, tachyplesin I, isolated from hemocytes of the horseshoe crab (Tachypleus tridentatus). NMR determination of the beta-sheet structure.从中国鲎(Tachypleus tridentatus)血细胞中分离得到的抗菌肽——鲎素I。β-折叠结构的核磁共振测定。
J Biol Chem. 1990 Sep 15;265(26):15365-7.
7
Molecular parameters for the anti-human immunodeficiency virus activity of T22 ([Tyr5,12, Lys7]-polyphemusin II).T22([酪氨酸5,12,赖氨酸7] - 海螯虾抗菌肽II)抗人类免疫缺陷病毒活性的分子参数
Biol Pharm Bull. 1994 Dec;17(12):1669-72. doi: 10.1248/bpb.17.1669.
8
Structure-activity relationships of an anti-HIV peptide, T22.抗HIV肽T22的构效关系
Biochem Biophys Res Commun. 1994 Dec 30;205(3):1729-35. doi: 10.1006/bbrc.1994.2868.
9
The synthetic [Tyr5,12,Lys7]-polyphemusin II peptide (T22) binds to the CD4 cell surface molecule.合成的[酪氨酸5,12,赖氨酸7] - 海胆精蛋白II肽(T22)与CD4细胞表面分子结合。
Biochem Biophys Res Commun. 1995 Oct 13;215(2):626-31. doi: 10.1006/bbrc.1995.2510.
10
Pharmacophore identification of a chemokine receptor (CXCR4) antagonist, T22 ([Tyr(5,12),Lys7]-polyphemusin II), which specifically blocks T cell-line-tropic HIV-1 infection.趋化因子受体(CXCR4)拮抗剂T22([酪氨酸(5,12),赖氨酸7] - 多聚半胱氨酸II)的药效团鉴定,该拮抗剂可特异性阻断T细胞系嗜性HIV-1感染。
Bioorg Med Chem. 1998 Jul;6(7):1033-41. doi: 10.1016/s0968-0896(98)00061-3.

引用本文的文献

1
An In Silico Methodology That Facilitates Decision Making in the Engineering of Nanoscale Protein Materials.一种有助于纳米尺度蛋白质材料工程设计中决策制定的计算方法。
Int J Mol Sci. 2022 Apr 29;23(9):4958. doi: 10.3390/ijms23094958.
2
Concerted Rolling and Penetration of Peptides during Membrane Binding.多肽在膜结合过程中的协同滚压和穿透。
J Chem Theory Comput. 2022 Jun 14;18(6):3921-3929. doi: 10.1021/acs.jctc.2c00014. Epub 2022 May 4.
3
Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4.
肿瘤标志物CXCR4的特异性肽配体T22的抗菌活性
Pharmaceutics. 2021 Nov 13;13(11):1922. doi: 10.3390/pharmaceutics13111922.
4
Ion-dependent slow protein release from disintegrating micro-granules.离子依赖性崩解微丸的缓慢蛋白释放。
Drug Deliv. 2021 Dec;28(1):2383-2391. doi: 10.1080/10717544.2021.1998249.
5
Structural and Biological Characterizations of Novel High-Affinity Fluorescent Probes with Overlapped and Distinctive Binding Regions on CXCR4.新型高亲和力荧光探针在 CXCR4 上重叠且独特的结合区域的结构和生物学特性。
Molecules. 2019 Aug 13;24(16):2928. doi: 10.3390/molecules24162928.
6
Structure and Biological Functions of β-Hairpin Antimicrobial Peptides.β-发夹抗菌肽的结构与生物学功能
Acta Naturae. 2015 Jan-Mar;7(1):37-47.
7
Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.皮肤肥大细胞通过触发肥大细胞受体 S1PR2 并释放抗菌肽来保护小鼠免受牛痘病毒感染。
J Immunol. 2012 Jan 1;188(1):345-57. doi: 10.4049/jimmunol.1101703. Epub 2011 Dec 2.
8
Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding.将鲎素I中的所有半胱氨酸删除可消除溶血活性,并保留抗菌活性和脂多糖选择性结合能力。
Biochemistry. 2006 May 23;45(20):6529-40. doi: 10.1021/bi052629q.
9
Lead optimization of antifungal peptides with 3D NMR structures analysis.通过三维核磁共振结构分析进行抗真菌肽的先导优化。
Protein Sci. 2004 Mar;13(3):703-13. doi: 10.1110/ps.03404404.
10
Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection.CXCR4拮抗剂T22对1型人类免疫缺陷病毒感染的抑制机制
J Virol. 1999 Sep;73(9):7489-96. doi: 10.1128/JVI.73.9.7489-7496.1999.